INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo COVOSTET

SCHEDULING STATUS:
S4

PROPRIETARY NAME
(and dosage form):

COVOSTET
Eye Drops

COMPOSITION:
Contains per mL:
        Tetracaine hydrochloride         5 mg
Preservative:
        Phenylmercuric acetate        0,002% m/v

PHARMACOLOGICAL CLASSIFICATION:
A. 15.4 Ophthalmic preparations. Other.

PHARMACOLOGICAL ACTION:
Tetracaine is a topical anaesthetic and is considerably more powerful than procaine or cocaine and tetracaine shows regularity in depth and duration of anaesthesia. It has minimal drying effects upon epithelium and does not dilate the pupil or disturb accommodation.

INDICATIONS:
For topical anaesthesia of the eye prior to tonometry or foreign body removal.

CONTRA-INDICATIONS:
Covostet should not be used on surfaces that are or will be extensively traumatised. Use with caution in allergic subjects particularly in patients allergic to topical anaesthetics of the caine series.

WARNINGS:
Do not use Covostet with mercury or silver salts. Do not use more than 30 days after opening.

DOSAGE AND DIRECTIONS FOR USE:
Apply one or two drops to the conjunctiva.
Not to be used while wearing contact lenses.

SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
Covostet occasionally causes smarting in the eye. On rare occasions lacrimation, photophobia, and chemosis in sensitive patients may be produced. Covostet may increase intra-ocular pressure and cause cardio-vascular collapse.
Local anaesthetics, can be used with safety in nearly all patients if suitable precautions are observed. They should be applied more sparingly on open lesions and in patients with allergy, cardiac and hepatic disease, emaciation, hyperthyroidism, and other endocrine disorders in which tolerance may be diminished. Long continued application of Covostet solution is not recommended.

IDENTIFICATION:
Clear solution.

PRESENTATION:
15 mL in an opaque dropper bottle with dropper insert and yellow cap.

STORAGE INSTRUCTIONS:
Store below 25°C. Keep tightly closed and protect from light.
Do not use more than 30 days after opening.
KEEP OUT OF REACH OF CHILDREN

REGISTRATION NUMBER:
F/15.4/10

NAME AND BUSINESS ADDRESS OF THE APPLICANT:
ADCOCK INGRAM LIMITED
Adcock Ingram Park
17 Harrison Avenue
Bryanston Ext.77
P/Bag X 69
Bryanston, 2021.

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
18 January 1974

New addition to this site: April 2004
Source: Pharmaceutical Industry

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2004